Clinical Trial Update: Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer [Phase 1]

View source ↗

Summary

Phase I trial evaluating mitomycin C combined with BCG for bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (Bacillus Calmette-Guérin)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Urinary Bladder Neoplasm | Phase 1 | Status: COMPLETED